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Abstract 
Incidental findings are not uncommon on medical imaging with a particularly high 
prevalence identified in the chest.  Pulmonary nodules contribute to a large 
proportion of incidental findings within the chest and these can often hinder definitive 
diagnosis because of their indeterminate nature.  This is especially true of the 
incidental findings demonstrated on low-resolution CT images produced during CT 
attenuation correction (AC), as utilised in single-photon emission tomography 
(SPECT).  The CTAC ‘images’ are effectively a by-product that were not intended for 
use in diagnosis. 
 
Although there is the potential for pulmonary nodules to become malignant, the 
majority will be benign. This gives rise to a high number of false-positive findings for 
CT imaging of the chest.  The high number of false-positive findings identified on 
CTAC images raises an issue of whether these images should be reviewed.  Whilst 
early detection of cancer could lead to earlier intervention and possibly improve 
prognosis, the high number of false-positive findings on CTAC images increases 
risks to the patient and does not necessarily raise the benefits.  The non-diagnostic 
quality of CTAC images usually necessitates further diagnostic tests and possibly 
intervention before a definitive diagnosis can be reached. 
 
A balanced decision needs to be made on whether to interpret CTAC chest images, 
given the high number of false-positive findings, the potential psychological effects 
and harms to the patient.  The recommendation of this review is that caution should 
be taken if routine reporting of CTAC images is to occur.  
 
Introduction 
Radiological imaging has advanced greatly since the discovery of x-rays by Wilhelm 
Roentgen in 1895. A broad range of imaging modalities are available that together 
can provide functional and anatomical detail (1).  Using a combination of imaging 
modalities, it is possible to demonstrate normal anatomy, pathology and disease 
process.   
 
Previously, when multiple imaging modalities were used in this way, image 
correlation was performed manually but it is becoming more common place now to 
integrate two modalities, one with functional capability and the other with anatomical 
capability, in the form of hybrid imaging.  An example of hybrid imaging would be in 
the combination of single-photon emission tomography (SPECT) and computerised 
tomography (CT).  Integration of the SPECT and the CT modalities provides for both 
functional and anatomical detail during one imaging session and, as such, minimises 
image mis-registration of image datasets (1),(2).   
 
The CT portion of SPECT-CT can be used to characterise pathology, to localise 
anatomy and pathology and for attenuation correction of the SPECT images.  
Characterisation of pathology usually requires a diagnostic quality scan and can 
involve the use of intravenous contrast agent.  It typically involves a higher ionising 
radiation dose to the patient than a localisation scan or a CT performed for 
attenuation correction (CTAC).   
 
The focus of this article will be specifically to CTAC images produced during SPECT-
CT for myocardial perfusion imaging (MPI).  The CTAC acquisition uses a low-dose 
technique that produces low-resolution (low-quality) images.  These CTAC images of 
the chest are prone to movement artifact because the patient is not required to 
breath-hold during the acquisition and the information gained is limited to a range 
through the cardiac area of the chest.   The acquisition is performed purely for 
attenuation correction of SPECT image data and not with the intention of an image 
being viewed for diagnosis.  However, CTAC images, which are essentially a by-
product of the process, often reveal incidental findings. 
 
Incidental findings  
An incidental finding is an unsuspected abnormality or anomaly that is not related to 
the clinical reason for the investigation (3),(4).  Incidental findings can be classified 
as clinically significant, clinically insignificant or indeterminate.  Radiologically, using 
the CTAC chest images it is often not possible to determine this definitively with the 
initial investigation.  True incidental findings (that are not known about prior to the 
investigation) and fall into the clinically significant or indeterminate category, will 
usually require follow-up diagnostic tests. 
 
Incidental findings within the chest are common and are frequently detected on low-
resolution CTAC images (5).  A high number incidental findings detected on CTAC 
images are classified as clinically significant or indeterminate at the time of the 
radiological report but, despite this, very few incidental findings remain clinically 
significant at definitive diagnosis. This leads to a high number of false-positive 
findings.  Table 1 lists some of the common incidental findings demonstrated on 
CTAC images. 
 
A large proportion of incidental findings within the chest are pulmonary nodules (6), 
which are often benign but can present radiologically as indeterminate or clinically 
significant.  This results in follow-up diagnostic investigations in order to reach 
definitive diagnosis. 
Significance of incidental findings on CTAC images 
Incidental findings that are known about from previous imaging are usually less of an 
issue than unknown incidental findings.  This is because, if it is considered 
necessary,  there will usually be a management plan in place at the time of CTAC 
acquisition.  Unknown incidental findings can prove more of a problem because 
decisions about further management will have to be made and these might not relate 
to the initial clinical indications for MPI imaging. 
 
Lung cancer has a poor prognosis, especially small cell lung cancer (SCLC).  Non-
small cell lung cancer (NSLC) has a better prognosis if detected at an early stage 
(7), (8).  There is an argument then for detecting and following up lung nodules that 
are considered to be clinically significant at the time of CTAC imaging if it is likely to 
improve prognosis.  However, follow up diagnostic tests and interventions carry with 
them potential risks as well as benefits to the patient.  
 
Results of lung cancer screening trials suggest that there needs to be a balance 
between early intervention to reduce mortality and risks of early morbidity and 
mortality from unnecessary intervention; mortality must be reduced and the benefits 
to the patient must outweigh the risks (6),(7).  Lung cancer screening with CT has 
not been adopted universally because of the high rate of false-positive findings and 
over-diagnosis of indolent tumours that might not have become significant in a 
patient’s lifetime. These findings have cost implications as well as increasing patient 
anxiety and morbidity (9).   
 
The lack of clarity surrounding lung cancer screening with CT raises the question of 
whether incidental findings should be looked for on CTAC images.  Whilst early 
diagnosis of pathology could potentially enable a better prognosis, detection of 
incidental findings can increase the risk to the patient without benefit.  Studies have 
shown that only a small percentage of incidental findings that are initially thought to 
be clinically significant on CTAC for SPECT MPI are actually clinically significant at 
definitive diagnosis.  The diagnostic examinations necessary to reach that definitive 
diagnosis often have risks associated with them that can cause physical or 
psychological harm to the patient as well as an increase in ionising radiation dose. 
Image quality 
CT image quality is dependent upon the acquisition parameters used and the way 
the data is reconstructed and viewed.  Although it would be desirable to achieve the 
best possible image quality, this often comes with the detriment of increased ionising 
radiation dose to the patient.  Therefore, image acquisition tends to be optimised 
(10) to the requirements of the examination so that the required image quality is 
achieved at the lowest radiation dose achievable. 
 
CTAC images are not considered to be diagnostic quality because of the typical 
acquisition parameters used.  The acquisition is purely for attenuation correction and 
not with the intention of image production.  This enables the radiation dose to the 
patient to be kept as low as reasonably practicable (ALARP). Typically, the CTAC 
acquisition uses a wide slice width and a low tube current (mA) that results in noisy 
images with poor contrast and poor spatial resolution.  In addition, the acquisition 
time is usually much longer than that of diagnostic CT and so patients are not 
required to breath-hold.  Images are therefore prone to motion artifact from 
breathing. 
Do CTAC MPI images have a diagnostic value? 
CTAC images tend to be low-resolution but incidental findings can still be detected.  
Some contemporary hybrid scanners have technical CT capabilities similar to those 
used for diagnostic imaging rather than the fixed acquisition parameters of earlier 
scanners. Therefore, it is possible, on some scanners, to improve the image quality 
by changing the acquisition parameters.  Protocols and imaging techniques can vary 
not just between different departments but also between different scanners.  This 
means that CTAC images from some scanners will be of better quality, and 
potentially more diagnostic, than from others (11). 
 
In non-clinical studies, lesion detection performance has been conducted using the 
Free-response Receiver Operating Characteristic (FROC) method to investigate 
detection of pulmonary nodules on a chest phantom using different acquisition 
parameters.  A study on one SPECT-CT system demonstrated that there was no 
statistically significant difference in lesion detection performance at different mA 
values when all other parameters remained unchanged (12).  In another lung 
phantom study involving a range of SPECT-CT systems, lesion detection varied 
relative the CT capability (13).  The same chest phantom was used in a study using 
two different SPECT-CT systems in which lesion detection was found to be more 
reliable on one of the systems but this was due to the reconstruction algorithms 
specific to that system rather than the acquisition parameters used (14).  However, 
these studies were all performed with a stationary phantom and so are not truly 
representative of a clinical study. 
 
In a 2-year multi-centre study in four nuclear medicine departments in the UK, 
incidental findings on CTAC images during SPECT-MPI were evaluated (15).  
Positive findings were identified on the CTAC images of 962 (28%) of 3485 patients 
of which 824 (24%) were new findings. Eighty-four (2.4%) patients had findings that 
were considered to be clinically significant at the time of imaging that were not 
known about previously.  Only 10 (0.29%) patients had findings that were confirmed 
to be clinically significant at definitive diagnosis.  In this study, 74 out of 84 patients 
had false-positive findings that involved follow up diagnostic tests and possibly 
intervention before a definitive, negative outcome was reached.  
 
The positive predictive value (PPV) across all the centres was low and statistically 
there was no significant difference between the PPV for CTAC images acquired 
using low resolution and better resolution machines.  The question of whether CTAC 
images should be reviewed was raised and the conclusion of the study was that 
routine reporting of CTAC images in this particular situation was not beneficial. 
Discussion 
There is the potential that early diagnosis of disease can reduce patient mortality. 
However, this is not always the case.  Early detection of lung cancer, in some cases, 
can lead to early intervention; in other cases the disease will have progressed too far 
by the time of diagnosis for curative intent to be an option.  Along with this, the 
indeterminate nature of some lung nodules necessitates surveillance.  This can be a 
lengthy process of up to 3 years (16) and can increase patient risks and anxiety. 
 
 Only a very small percentage of findings on CTAC images have been found to be 
malignant or detrimental to the patient at definitive diagnosis.  None-the-less, a high 
percentage of findings will require further imaging or intervention until a definitive 
diagnosis has been reached.  Again, this can increase risks to the patient and 
increase morbidity. 
 
Screening programmes and other imaging programmes often have a structured 
support system in place for patients to help them cope with their diagnosis.  In case 
of incidental findings, there is often a lack of support due to the unexpected nature of 
the finding.   Given that incidental findings on CTAC during SPECT-MPI are 
common, there are likely to be a significant number of patients who would benefit 
from extra support.  False-positive findings or over diagnosis can greatly increase 
patient anxiety and patients often have a natural assumption that any incidental 
finding is cancer (17). 
Conclusion 
Until now CTAC images from SPECT MPI studies are low-resolution and not 
considered to be diagnostic.  Demonstration of pathology and incidental findings is 
possible but there is also the potential to miss pathology that has not been 
sufficiently demonstrated or not demonstrated at all on CTAC images.  
 
Producing a routine report for CTAC images from CTAC images arising from 
SPECT-MPI has been called into question (18). Consequnetly caution should be 
taken when reporting CTAC images and the report should state clearly that the 
images are low-resolution and not intended for diagnostic purposes.  The potential 
impact to the patient for any incidental findings should be considered during this 
process. 
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Table 1 – Examples of incidental findings on SPECT-CT images of the chest 
 
Incidental Finding 
 
Coronary vessel calcification 
Vascular anomalies 
Valve replacement 
Pacemaker 
Atelectasis 
Effusion 
Consolidation 
Lobar collapse 
Nodules 
Mass 
Pulmonary metastases 
Ground glass opacities 
Aortic aneurysm 
Source: Adapted from (Coward et al, 2014)  
 
